Chemotherapy Induced Peripheral Neuropathy Market Analysis and Outlook Report: Industry Size, Share, Growth Trends, and Forecast (2026-2034)
The chemotherapy-induced peripheral neuropathy (CIPN) market is gaining visibility as oncology care increasingly prioritizes survivorship, quality of life, and long-term functional outcomes alongside tumor control. CIPN is a common and often dose-limiting adverse effect of several widely used chemotherapies, characterized by sensory symptoms (numbness, tingling, burning pain), motor impairment,...
0 Comments 0 Shares 48 Views 0 Reviews
Sponsored